Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis
Frontiers in Cellular and Infection Microbiology · 20.04.2023 · 13
DOI: 10.3389/fcimb.2023.1157010 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 20.04.2023. Verfasst von Dan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Klebsiella Infections, Bacteremia. Die Arbeit wurde bisher 103-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To analyze the mortality rate of patients with Klebsiella pneumoniae bacteremia (KPB) and the impact of extended spectrum beta-lactamase (ESBL) producing or carbapenem-resistance (CR) KP on the mortality rate among patients with bacteremia.
Methods
EMbase, Web of Science, PubMed, and The Cochrane Library were searched up to September 18 th , 2022. Two reviewers independently extracted data and evaluated risk of bias of included studies by ROBINS-I tool. A meta-regression analysis was conducted using a mixed-effects model to explore possible sources of heterogeneity. A random-effects model was used for pooled analysis in case of significant heterogeneity (I 2 >50%). Otherwise, the fixed-effects model was performed.
Results
A total of 157 studies (37,915 enrolled patients) were included in the meta-analysis. The pooled death proportions of KPB were 17% (95% CI=0.14-0.20) at 7-day, 24% (95% CI=0.21-0.28) at 14-day, 29% (95% CI=0.26-0.31) at 30-day, 34% (95% CI=0.26-0.42) at 90-day, and 29% (95% CI=0.26-0.33) in hospital, respectively. Heterogeneity was found from the intensive care unit (ICU), hospital-acquired (HA), CRKP, and ESBL-KP in the meta-regression analysis. More than 50% of ICU, HA, CRKP, and ESBL-KP were associated with a significant higher 30-day mortality rates. The pooled mortality odds ratios (ORs) of CRKP vs . non-CRKP were 3.22 (95% CI 1.18-8.76) at 7-day, 5.66 (95% CI 4.31-7.42) at 14-day, 3.87 (95% CI 3.01-3.49) at 28- or 30-day, and 4.05 (95% CI 3.38-4.85) in hospital, respectively.
Conclusions
This meta-analysis indicated that patients with KPB in ICU, HA-KPB, CRKP, and ESBL-KP bacteremia were associated with a higher mortality rate. The high mortality rate caused by CRKP bacteremia has increased over time, challenging the public health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
- Department of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
- Department of Laboratory Medicine, Medical Center Hospital of Qionglai City, Chengdu, Sichuan, China.
- College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Zitieren
APA
Li, D., Huang, X., Rao, H., Yu, H., Long, S., Li, Y., & Zhang, J. (2023). Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1157010
Vancouver
Li D, Huang X, Rao H, Yu H, Long S, Li Y, et al. Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1157010
BibTeX
@article{Li2023,
author = {Li, Dan and Huang, Xiangning and Rao, Huayun and Yu, Hua and Long, Shanshan and Li, Yulian and Zhang, Jie},
title = {Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
volume = {13},
doi = {10.3389/fcimb.2023.1157010}
}
EUVIMED